Rafarm S.A.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Greece
- Registered address
- Thesi Pousi-Hatzi Agiou Louka, Paiania, Attiki 19002, Greece (GRC)
- Operations here
- manufacture
- FDA identifiers
- FEI 3009592290 · DUNS 506963742
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-06-21
- NAIBioresearch Monitoring2023-05-19
- VAIDrug Quality Assurance2021-06-04
- NAIBioresearch Monitoring2020-03-11
- VAIDrug Quality Assurance2018-05-31
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- DifluprednateUpsher-Smith Laboratories, LLC
- Norepinephrine BitartrateBreckenridge Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.